Through its wholly owned subsidiary Mimotopes Pty Ltd, has today signed a new three-year contract with Invitrogen Corporation to exclusively supply research-grade peptides to Invitrogen’s worldwide customer base.
Subscribe today for award-winning, unbiased and trusted journalism